S 
Sunshine Guojian Pharmaceutical Shanghai Co 688336.SS · CNY
Health Care · Shanghai · 🇨🇳 China
33.16
-0.33%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥4.20bn
FY2016FY2025
Net income
CN¥2.94bn
FY2016FY2025
Free cash flow
CN¥2.79bn
FY2016FY2025
Shareholders' equity
CN¥5.86bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥4.20bn | CN¥1.19bn | CN¥1.01bn | CN¥825.5m | CN¥928.8m | CN¥655.0m | CN¥1.18bn | CN¥1.14bn | CN¥1.10bn | CN¥961.4m |
| Gross profit | CN¥4.20bn | CN¥888.9m | CN¥791.0m | CN¥620.7m | CN¥718.8m | CN¥552.7m | CN¥1.03bn | CN¥1.02bn | CN¥998.7m | CN¥893.4m |
| Research and development | CN¥435.0m | CN¥356.5m | CN¥282.3m | CN¥313.3m | CN¥455.1m | CN¥340.2m | CN¥278.9m | CN¥198.7m | CN¥122.3m | CN¥175.6m |
| Operating income | CN¥3.29bn | CN¥726.5m | CN¥318.2m | CN¥36.9m | −CN¥43.6m | −CN¥203.1m | CN¥259.8m | CN¥421.5m | CN¥440.9m | CN¥263.4m |
| Net income | CN¥2.94bn | CN¥704.6m | CN¥294.6m | CN¥49.3m | CN¥18.1m | −CN¥217.5m | CN¥229.3m | CN¥369.7m | CN¥388.7m | CN¥268.1m |
| Diluted earnings per share | 4.67 | 1.11 | 0.46 | 0.08 | 0.03 | -0.34 | 0.37 | 0.59 | 0.62 | 0.43 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥8.96bn | CN¥5.97bn | CN¥5.31bn | CN¥5.10bn | CN¥4.89bn | CN¥4.95bn | CN¥3.32bn | CN¥3.70bn | CN¥3.34bn | CN¥2.89bn |
| Cash and short-term investments | CN¥1.72bn | CN¥1.37bn | CN¥1.88bn | CN¥2.58bn | CN¥2.37bn | CN¥2.71bn | CN¥1.14bn | CN¥202.0m | CN¥338.6m | CN¥356.0m |
| Total liabilities | −CN¥5.86bn | CN¥428.1m | CN¥426.5m | CN¥498.9m | CN¥349.7m | CN¥433.4m | CN¥416.3m | CN¥427.0m | CN¥426.9m | CN¥340.2m |
| Debt | — | CN¥50.0m | CN¥50.0m | CN¥150.1m | — | — | — | CN¥6.9m | CN¥7.2m | — |
| Shareholders' equity | CN¥5.86bn | CN¥5.57bn | CN¥4.90bn | CN¥4.61bn | CN¥4.54bn | CN¥4.50bn | CN¥2.87bn | CN¥3.22bn | CN¥2.85bn | CN¥2.46bn |
| Shares outstanding | 629m | 632m | 634m | 606m | 693m | 644m | 623m | 629m | 629m | 629m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥3.04bn | CN¥281.1m | CN¥416.4m | CN¥233.5m | −CN¥243.8m | −CN¥40.1m | CN¥587.6m | CN¥361.3m | CN¥235.1m | CN¥354.4m |
| Capital spending | −CN¥252.9m | −CN¥280.8m | −CN¥235.7m | −CN¥221.3m | −CN¥263.8m | −CN¥227.0m | −CN¥130.2m | −CN¥90.1m | −CN¥69.1m | −CN¥104.7m |
| Free cash flow | CN¥2.79bn | CN¥354,310 | CN¥180.6m | CN¥12.2m | −CN¥507.6m | −CN¥267.1m | CN¥457.4m | CN¥271.2m | CN¥166.0m | CN¥249.6m |
| Dividends paid | −CN¥76.5m | −CN¥51.2m | −CN¥1.5m | −CN¥1.2m | −CN¥1.2m | −CN¥1.2m | −CN¥716.5m | — | — | −CN¥152,709 |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥434.5m | CN¥431.2m | CN¥3.08bn | CN¥474.0m | CN¥330.9m | CN¥311.1m | CN¥254.2m | CN¥342.8m |
| Gross profit | CN¥348.7m | CN¥348.0m | CN¥3.34bn | CN¥406.6m | CN¥215.0m | CN¥236.1m | CN¥180.8m | CN¥270.7m |
| Operating income | CN¥149.4m | CN¥191.4m | CN¥2.87bn | CN¥232.6m | CN¥75.9m | CN¥113.8m | CN¥464.9m | CN¥112.0m |
| Net income | CN¥193.2m | CN¥178.1m | CN¥2.54bn | CN¥208.5m | CN¥87.4m | CN¥103.0m | CN¥471.5m | CN¥103.5m |
| Diluted earnings per share | 0.31 | 0.28 | 4.04 | 0.33 | 0.14 | 0.16 | 0.75 | 0.16 |
| Cash from operations | — | — | — | CN¥2.63bn | CN¥89.0m | CN¥98.0m | — | CN¥493.0m |
| Capital spending | −CN¥58.0m | −CN¥48.0m | −CN¥95.0m | −CN¥65.0m | −CN¥53.0m | −CN¥38.0m | −CN¥102.0m | −CN¥61.0m |
| Free cash flow | — | — | — | CN¥2.56bn | CN¥36.0m | CN¥60.0m | — | CN¥432.0m |
| Total assets | CN¥8.79bn | CN¥8.95bn | CN¥8.96bn | CN¥8.81bn | CN¥6.01bn | CN¥6.04bn | CN¥5.97bn | CN¥5.92bn |
| Cash and short-term investments | — | — | CN¥1.72bn | CN¥1.72bn | CN¥1.32bn | CN¥1.37bn | CN¥1.37bn | CN¥1.32bn |
| Debt | — | — | — | — | — | CN¥50.0m | CN¥50.0m | CN¥50.0m |
| Shareholders' equity | CN¥8.50bn | CN¥8.62bn | CN¥5.86bn | CN¥5.90bn | CN¥5.70bn | CN¥5.67bn | CN¥5.57bn | CN¥5.07bn |
Financial ratios
Data as of 19 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2013 | FY2009 | FY2008 | |
|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 100.0% | 74.5% | 78.0% | 75.2% | 77.4% | 84.4% | — | — | — |
| Operating margin | 78.4% | 60.9% | 31.4% | 4.5% | -4.7% | -31.0% | — | — | — |
| Net margin | 70.0% | 59.0% | 29.1% | 6.0% | 1.9% | -33.2% | — | — | — |
| Return on equity | 50.2% | 12.7% | 6.0% | 1.1% | 0.4% | -4.8% | — | — | — |
| Return on assets | 32.8% | 11.8% | 5.6% | 1.0% | 0.4% | -4.4% | — | — | — |
| Free cash flow yield | 13.0% | 2.2% | 2.6% | 1.9% | 0.1% | 0.7% | — | — | — |
| Revenue growth | 251.8% | 17.7% | 22.8% | -11.1% | 41.8% | -44.4% | — | — | — |
| Earnings growth | 317.1% | 139.2% | 497.6% | 173.0% | -108.3% | -194.8% | — | — | — |
| Current ratio | 13.94x | 8.39x | 7.30x | 7.96x | 13.33x | 11.14x | — | — | — |
| Debt to equity | — | 0.01x | 0.01x | 0.03x | — | — | 0.11x | 0.03x | 0.05x |
| Equity ratio | 65.4% | 93.3% | 92.3% | 90.3% | 92.9% | 90.9% | — | — | — |
| Interest coverage | 5783.84x | 618.00x | 199.91x | 28.07x | -253.72x | -1662.26x | — | — | — |
| R&D as a share of sales | 10.4% | 29.9% | 27.8% | 38.0% | 49.0% | 51.9% | — | — | — |
| Buybacks as a share of market value | 0.6% | 0.2% | -4.5% | 12.5% | -7.6% | -3.4% | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 72.0% | 45.0% | 16.9% |
| Operating income | 346.7% | — | 33.2% |
| Net income | 290.6% | — | 30.2% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 94.3% | 89.9% | 88.1% | 89.1% |
| Operating margin | 74.5% | 60.5% | 46.8% | 40.5% |
| Net margin | 67.6% | 55.1% | 43.0% | 37.3% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Price to earnings | 12.7 | 19.2 | 48.4 | 156.2 | — | -73.0 |
| Price to sales | 8.9 | 11.3 | 14.1 | 9.3 | 13.8 | 24.2 |
Dividends and splits
Per share, in the currency the company pays
Paid for 2 years. Last went ex-dividend on 18 Jun 2026.
| FY2026 | FY2025 | FY2024 | |
|---|---|---|---|
| Paid in the year | 0.45 | 0.085 | 0.057 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.